Zbtb14 regulates monocyte and macrophage development through inhibiting pu.1 expression in zebrafish

Yun Deng1,2, Haihong Wang1,2, Xiaohui Liu1,2

  • 1Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Elife
|October 7, 2022
PubMed

Insights

Zbtb14 deficiency causes abnormal monocyte/macrophage expansion by regulating PU.1. A mutation linked to acute myeloid leukemia (AML) affects ZBTB14 protein stability, implicating it in myelopoiesis.

Area of Science:

  • Immunology and Developmental Biology
  • Molecular Genetics and Cancer Research

Background:

  • Monocytes and macrophages are crucial immune cells involved in pathogen defense and tissue repair.
  • Proper development of monocytes/macrophages relies on specific transcription factors like PU.1.

Purpose of the Study:

  • To investigate the role of the transcription repressor gene Zbtb14 in monocyte/macrophage development.
  • To elucidate the mechanism by which Zbtb14 regulates myelopoiesis.
  • To explore the implications of ZBTB14 in malignant conditions like acute myeloid leukemia (AML).

Main Methods:

  • Utilized zebrafish as a model organism to study gene function in vivo.
  • Investigated the regulatory relationship between Zbtb14 and PU.1.
  • Examined the role of SUMOylation in Zbtb14's transcriptional repression activity.
  • Analyzed the impact of an AML-associated mutation on ZBTB14 protein stability and degradation pathways.

Main Results:

  • Zebrafish lacking Zbtb14 exhibited an aberrant expansion of the monocyte/macrophage population.
  • Zbtb14 acts as a negative regulator of PU.1, a key transcription factor in myelopoiesis.
  • SUMOylation of Zbtb14 is essential for its repressive function.
  • An AML patient mutation (Serine to Phenylalanine) targets ZBTB14 for autophagic degradation.

Conclusions:

  • Zbtb14 is a novel gene that plays a critical role in regulating normal monocyte/macrophage development.
  • Dysregulation of Zbtb14, potentially through altered protein stability, is implicated in the pathogenesis of AML.
  • ZBTB14 is a newly identified player in both normal and malignant myelopoiesis.

Related Concept Videos